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1. Executive Summary 
   
  The prostate is a key component of the male reproductive system. Often, due to age, the 
prostate  becomes  enlarged  resulting  in  a  condition  known  as  Benign  Prostatic  Hyperplasia 
(BPH).  While  pharmacological  options  are  generally  the  first  choice,  surgery  is  sometimes 
necessary to treat this condition. Laser procedures are ideal because of the decreased risks to the 
patient, but complications arise when the layer of coagulated tissue created by the laser becomes 
too thick. An ideal laser wattage and application time must be determined in order to minimize 
the  coagulation  layer  while  achieving  an  effective  level  of  vaporization.  The  goal  of  this 
simulation  was  to  create  a  model  from  which  an  ideal  set  of  laser  parameters  for  the  laser 
treatment of BPH can be determined. This was achieved using finite-element analysis of the laser 
heating of a 2-dimensional axisymmetric prostate model using COMSOL Multiphysics software. 
Using this simulation, the vaporization and coagulation thicknesses in prostatic tissue treated for 
5 seconds with a 40W, 80W, or 120W laser, or treated for 1 second with a 60W, 80W or 120W 
laser were determined.   The results indicated that increasing laser wattage and/or application 
time  increases  the  thickness  of  vaporized  tissue  and  decreases  the  thickness  of  coagulation.  
Furthermore, the results suggested that the thickness of the coagulation zone converges to a 
minimum  value  as  wattage  and/or  application  time  is  increased.    This  simulation  was 
preliminary;  however,  this  model  can  ideally  be  used  to  determine  an  ideal  laser  wattage-
application time combination that produces the desired level of vaporization while minimizing 
tissue coagulation.   3 
 
2. Introduction 
 
2.1 Background Information  
Located  below  the  bladder  surrounding  the  urethra,  the  prostate  gland  is  an  essential 
component of the male reproductive system.  A normal prostate is slightly larger than a walnut; 
measuring, on average, 4.4 cm across, 2.6 cm from front to back, and 3.4 cm in length
 and 
weighing  about  20  grams  (+/-  6  grams)  between  ages  21  and  30
(1,2).  In  the  absence  of 
complications, the prostate will remain this size for the duration of a lifespan 
(2).   
Unfortunately,  a  significant  portion  of  the  male  population  above  the  age  of  50  will 
experience  some  kind  of  prostatic  complications.    Age  related  prostatic  enlargement,  often 
referred to as Benign Prostatic Hyperplasia (BPH), can begin after age thirty and is estimated to 
effect between 8-20% of the male population in their forties, and 50% of the male population 
over  50 
(2,3).      The  histology  of  BPH  is  characterized  by  the  growth  of  nodules  within  the 
prostate, which can lead to compression of the urethra due to barriers to outward growth 
(1,3).  In 
some cases this compression is mild with no bothersome symptoms, but in obstructive cases 
BPH can interfere with normal urination or in extreme cases completely block the urethral canal.  
BPH becomes a clinical problem when patients develop bothersome symptoms, which include 
difficulty  in  or  inability  to  completely  empty  the  bladder,  hesitancy  (difficulty  beginning  to 
urinate), weak stream, incontinence, and urinary tract infections 
(3). The American Urological 
Association has established a reliable symptom index for BPH which includes seven questions 
relating  to  frequency,  nocturia,  weak  urinary  stream,  hesitancy,  intermittence,  incomplete 
emptying and urgency 
(4).  These clinical symptoms are collectively referred to as lower urinary 
tract symptoms (LUTS) and manifest in approximately 50% of men with histological evidence of 
BPH 
(3).   
The range of severity in BPH symptoms and their impact on daily life leads to a similar 
diversity in treatment strategies.  For example, in mild cases, BPH is often treated with „watchful 
waiting‟ and frequent reassessment of symptoms, whereas the most obstructive cases  require 
some type of surgical intervention 
(3). Pharmacological strategies, such as administration of alpha 
blockers  or  5-alpha  reductase  inhibitors,  are  also  commonly  used  to  manage  BPH 
(3).    The 
disadvantage to alpha blockers, which work by relaxing smooth muscle to relieve LUTS, is their 
potential to cause hypotension as they do not discriminately affect the smooth muscle of the 
bladder and urethra and can also affect vascular smooth muscle
(3).  When medical interventions 
prove unsuccessful surgical procedures are considered.  Transurethral resection of the prostate 
(TURP) is the surgical removal of prostate tissue using electrocautery or dissection. TURP is the 
standard  surgical  treatment  of  BPH  due  to  the  substantial  data  confirming  its  efficacy 
(3).  
However, TURP has significant disadvantages.  As with any surgical procedure, TURP requires 
anesthesia and may cause bleeding as well as an electrolyte imbalance due to the use of a bladder 
irrigant
(3).  Long-term complications include sexual dysfunction and the need for reoperation 
within  two  years  for  2  out  of  30  TURP  patients 
(3).    Due  to  these  disadvantages,  effective 
alternatives to TURP are in demand and many are being used today.   
Laser procedures are a desirable surgical alternative to TURP as they achieve similar results 
with a lower tendency for bleeding and less post procedure morbidity
(3).  Various effective laser 
procedures  exist,  but  complications  still  arise  when  the  laser  procedure  produces  a  thick 
coagulation zone.  For example, an Nd:YAG laser vaporizes only a small amount of tissue and 
induces  deep  coagulation  which  can  cause  accumulation  of  fluid  and  prolonged  urinary 
retention
(5).  Therefore, of particular interest is laser prostatectomy using a green light laser, also 
known as photoselective vaporization of the prostate (PVP)
(6).  The aim of PVP is to selectively 
vaporize a region of the enlarged prostate tissue to alleviate obstruction of the urethra.  PVP 
results in a thin (1-2 mm) coagulation zone which is successful in sealing blood vessels and 4 
 
preventing the problems associated with an Nd:YAG laser
(5). PVP has been demonstrated to be 
as  or  more  effective  than  alternative  procedures,  with  persistent  results  (up  to  5  years  post 
procedure) and less complications
(6).  This long-term efficacy may be the final evidence needed 
for PVP to replace TURP as the standard surgical treatment for BPH.  As a result, it is critical to 
examine the PVP procedure and understand the implications it may have on the future of BPH 
treatment.   
 
2.2 Design Objectives 
Vaporization of tissue occurs  due to  boiling of water within the tissue and the resulting 
pressure of water vapor bubbles on the collagen matrix.  Therefore, for tissue to be vaporized the 
temperature  must  reach  100
oC.    Coagulation  of  tissue  occurs  when  proteins  in  the  tissue 
denature, which occurs between 60-65
oC.  Coagulation is important as it helps seal the tissue to 
prevent bleeding, but when coagulated tissue becomes too thick it can lead to complications.  
The PVP laser procedure produces only a thin layer of coagulation beyond the vaporized region. 
This is particularly effective, as it limits some of the post surgery problems associated with 
necrotic tissue produced in laser procedures that aim to cause only coagulation of the tissue.   
Our main objective is to model the effects of a PVP procedure using a high power potassium-
titanyl phosphate (KTP) green light laser on the tissue of an enlarged prostate.  Specifically, our 
goal is to examine the effects of various laser wattages and application times on the temperature, 
vaporization depth, and coagulation zone thickness of the prostate and surrounding tissue. We 
aim to determine the quantitative effects of: (1) increasing laser wattage from 40 to 120W, and 
(2) increasing application time from 1 to 5 seconds    
 
2.3 Problem Schematic 
For  the  purposes  of  modeling  the  KTP  laser  surgery  the  walnut  shaped  prostate  was 
approximated as a cylinder.  This approximation created axisymmetry about the z axis and lateral 
symmetry about the r axis which enabled us to reduce the complexity of our model by focusing 
on one quarter of the prostate (Figure 2.3.1(b))._  
(a)    (b)  
 
Figure 2.3.1. (a) Biological Schematic showing physical anatomy of the prostate. (b)  Model 
schematic of the prostate and surrounding tissue with the prostate approximated as a cylinder 
with a diameter of 4 cm (including urethra) and height of 3 cm, and offset 2.5 mm from the z-
axis to account for the urethra.  There is 2D axisymmetry about the z-axis and lateral symmetry 
about the r-axis. (Note: schematic is not drawn to scale)  5 
 
3. Results and Discussion 
 
3.1 Mathematical Background 
The governing equations used for our model included the transient heat transfer equation 
with a source term, the light diffusion equation, and a mass diffusion equation for moisture 
content (Appendix A).  The heat transfer equation was used to solve for temperature within the 
computational domain.  This required implementation of the light diffusion equation to find the 
fluence rate (φ) as the heat source term was defined as the product of the absorption coefficient 
(µa)  and  the  fluence  rate  (φ).    Finally,  a  mass  diffusion  model  was  used  to  determine  the 
moisture content of the tissue as it affects the absorption coefficient (µa), and therefore, the heat 
source term.  Further information on the solution strategy, such as the software used or meshing, 
can be found in Appendix B.   
 
3.2 Temperature Profile 
The  completion  of  this  model  gives  a  quantitative  look  at  KTP  laser  surgery.    For  a 
preliminary test, an 80 W laser power with a 1 second run time was used to obtain a spatial 
image of the temperature of the prostate.  Only a small region of the prostate and surrounding 
was heated above the vaporization temperature of 373 K (Figure 3.2.1).  Under these conditions, 
approximately 1.17 mm of the prostate tissue was vaporized and damage to the surrounding 
tissue was limited to a small region where the prostate and surrounding tissue meet (Figure 
3.2.2.).    
 
 
Figure 3.2.1.  Surface Plot of Model: Plot of temperature after 1 second of heating at 80W. This 
plot shows that a small section of the prostate region adjacent to the urethra is heated with 
minimal heating in the surrounding tissue.  A small portion of the surrounding tissue above the 
prostate urethra interface is heated.  
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Figure 3.2.2.  Surface Plot of Prostate: Close up of the heated prostate region after 1 second of 
heating at 80W.  This shows an ablation region of the prostate adjacent to the urethra that is 
heated to approximately 373K.  Past this region there is a temperature gradient and then the 
surrounding tissue and majority of the prostate is still at the initial temperature of 310K.  
 
The maximum temperature in the prostate is approximately 373K. This temperature is just 
high enough to  vaporize the tissue (Figure 3.2.2). For the 80W laser the surrounding tissue 
directly  above  the  prostate  is  being  heated  to  a  maximum  temperature  of  374.7K.    This  is 
misleading because the moisture content equation is not being implemented in the surrounding 
tissue due to the extremely long running time. If the vaporization of the water in the surrounding 
tissue were being accounted for, the maximum temperature would be significantly lower and 
there would be minimal damage to this tissue.  Additionally, a point in the prostate tissue was 
selected and a plot of the change in temperature over the run time was created (Figure 6.3.1).  
The  temperature  change  with  time  is  fairly  linear,  with  an  approximate  increase  of  10 
degrees/second.   
Furthermore, to examine the role that moisture content played in the temperature profile the 
moisture content of the prostate after 1 second of laser heating at 80 W was plotted (Figure 
6.3.2).  As expected, the moisture content dropped dramatically in the ablated region of the 
prostate and remained constant in the majority of the prostate tissue.   
 
3.3 Vaporization and Coagulation Zones 
To elucidate the vaporization zone versus the coagulation zone, a contour plot was created 
(Figure 3.3.1).  The first contour line is at 373 K, showing the section of prostate vaporized.  The 
other two contour lines  are at  338 and 333 K showing the range of  thicknesses  of prostate 
coagulation.  Because  tissue  coagulation  causes  severe  negative  side  effects,  coagulation 
thickness was calculated using the 333K contour to determine the maximum possible coagulation 
thickness.  Therefore,  coagulation  thickness  was  defined  as  the  distance  between  the  333  K 
contour and the 373 K contour corresponding to the edge of the vaporization zone.   7 
 
 
Figure 3.3.1.  Coagulation and Vaporization Zones: Contour plot of prostate region at 1 second at 
80W, showing contours at 333 K, 338 K, and 373 K, which correspond to coagulation and 
vaporization  temperatures.    Vaporization  depth  was  determined  to  be  1.17  mm  and  the 
coagulation depth was 0.795 mm. 
 
3.4 Wattage and Run Time Variation 
To further understand the effects of laser wattage and application time on KTP laser 
surgery the model was run with variations in these two parameters.  First, laser wattage was 
changed to 60W or 120 W with a 1 second run time.  The contour plots for these wattages can be 
found in Appendix C (Figures 6.3.3 and6.3.4).  Next, the run time was increased to  5 seconds 
with laser wattages of 40, 80, and 120 W.  In this case, 40W was used instead of 60W to 
facilitate validation of the model, which is discussed further in section 3.5.  The contour plots for 
these runs can be found in Appendix C (Figure 6.3.5 through 6.3.7).  As expected, vaporization 
thickness, defined as the distance between the prostate edge and the 373 K contour, increased as 
laser  wattage  increased  (Figure  3.4.1).    Additionally,  vaporization  thickness  increased  as 
application time increased (Figure 3.4.1).     However,  coagulation  thickness,  defined as  the 
distance between the 333 K contour and the 373 K contour, decreased as laser wattage increased 
(Figure  3.4.2).    For  identical  wattages  coagulation  thickness  increased  as  application  time 
increased, but at higher wattages, the difference between the 1 second and 5 second coagulation 
thicknesses decreased (Figure 3.4.2). This indicates that coagulation zone thickness converges to 
a minimum and is unavoidable, which is ideal as coagulation is necessary to seal the tissue at the 
edge of the vaporization zone and prevent bleeding.   
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Figure 3.4.1. Vaporization Depth: Trends in the depth of the vaporization zone of the prostate as 
the laser wattage and run time parameters are varied. 
 
 
Figure 3.4.2. Coagulation Depth: Trends in the depth of the coagulation zone of the prostate as 
the laser wattage and run time parameters are varied. 
 
3.5 Validation 
To validate the model, its results were compared to experimental results of previous research 
on  the  effects  of  laser  heating  of  canine  prostate  tissue.
(17)  The  experimental  results  were 
obtained by measuring the vaporization and coagulation thicknesses in canine prostate tissue 
treated with 40, 80, and 120W lasers for 5 seconds
(17).     These values were plotted against the 
coagulation and vaporization thicknesses determined by simulation of similar procedures using 
the model(Figures 3.5.1 and 3.5.2).     9 
 
 
Figure 3.5.1. Coagulation Thickness Validation: The simulated and experimental coagulation 
thicknesses in the prostate after 5 seconds with  laser powers of 40, 80, and 120W. 
In  both  the  experimental  and  the  simulated  data,  there  is  a  decreasing  trend  in  the 
coagulation  thickness  as  the  laser  power  increases.  The  simulated  coagulation  thicknesses, 
however, are all at least 1 mm smaller than the experimental values (Figure 3.5.1). 
 
 
Figure 3.5.2. Vaporization Thickness Validation: The simulated and experimental vaporization 
thicknesses in the prostate after 5 seconds with  laser powers of 40, 80, and 120W. 
In both the simulation and the experimental data the vaporization thickness increases with laser 
power. The simulated thickness is more than 2mm less than the experimental thickness at a laser 
power  of  40W,  but  this  difference  decreases  to  slightly  larger  than  1mm  as  the  power  is 
increased  to  120W  (Figure  3.5.2).  Some  of  the  differences  between  the  simulated  and 
experimental values may be caused by the differences between human and canine prostate tissue 
properties, since human tissue properties were used in the simulation but the experiment was 
performed on canine tissue.    10 
 
3.6 Sensitivity Analysis 
Since accurate property data are not always available, a sensitivity analysis was performed to 
examine the effects of parameter variability.  Tissue parameters, such as density, specific heat 
capacity,  and  thermal  conductivity  were  varied  by  +/-  10%  from  their  original  value.    This 
indicated which parameters were sensitive to changes and how variation in parameter values 
affected the objective function: average prostate tissue temperature (Figure 3.6.1).    
 
 
Figure 3.6.1. Sensitivity Analysis: Analysis for density, heat capacity, and thermal conductivity, 
varying each parameter by +/- 5% and +/- 10% to obtain the effect this had on average prostate 
temperature.  
 
Changes in both the density and the heat capacity had a noticeable and equivalent effect on 
the average prostate temperature (Figure 3.6.1). This  is  intuitive, since  these parameters are 
multiplied together in the governing equation. The total variation between -10% and +10% for 
both the density and the heat capacity is .54K, with the average temperature decreasing with 
increasing  parameter  values  (Figure  3.6.1).  The  thermal  conductivity  affected  the  average 
prostate temperature minimally, with a difference of only .03K between the -10% and +10% 
values (Figure 3.6.1). This analysis indicated that larger importance needed to be placed on 
accurate  density  and  heat  capacity  values  as  their  variation  resulted  in  larger  temperature 
variation.    
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4. Conclusions and Design Recommendations 
 
4.1 Conclusions 
The primary objective of this project was to model the effects of a PVP procedure on an 
enlarged prostate using a KTP laser.  Using COMSOL, the effect of an 80W KTP laser targeting 
an enlarged prostate was modeled to find its effect on the temperature, thickness of coagulation, 
and thickness of vaporization in the prostate.  Simulation of an80 W laser applied for 1 second 
indicated that a small portion of the prostate reached a maximum temperature of 373 K, while 
the rest of the prostate along with the surrounding tissue remained at the initial temperature of 
310 K (Figure 3.2.2).  The contour plot showed a coagulation thickness of 0.795 mm and a 
vaporization  thickness  of  1.17  mm  (Figure  3.3.1).    Additionally,  by  running  the  model  for 
different laser powers, i.e. 40 W, 60 W, and 120 W, with run times of 1 second and 5 seconds, it 
was  concluded  that  both  coagulation  and  vaporization  thicknesses  were  dependent  on  the 
magnitude of laser wattage.  More specifically, coagulation depth decreased with increased laser 
wattage  and  vaporization  depth  increased  with  increased  laser  wattage.    Comparing  the 
coagulation thicknesses with respect to run time, the coagulation depths for a run time of 5 
seconds were slightly larger (by less than a factor of 1), yet nearly equivalent to the coagulation 
depths for a run time of 1 second.  On the other hand, the vaporization depths for a run time of 5 
seconds were about twice to three times greater in magnitude than those for a run time of 1 
second.    Such behavior could be due to the fact that as run time was increased, the laser emitted 
thermal energy for a longer period of time on  the prostate,  and therefore,  heat  input to  the 
prostate increased, which led to greater degrees of vaporization.   
Results  from  conducting  a  sensitivity  analysis  for  the  three  parameters,  density,  heat 
capacity, and thermal conductivity, indicated that changes in thermal conductivity had minimal 
effects on the average temperature of a prostate, while changes in density and heat capacity 
values  had  significant  effects,  both  of  which  had  average  prostate  temperatures  that  were 
extended over a range of 316.69 K to 317.23 K.  In order to check the accuracy and validity of 
our model, we referenced past research conducted on laser treatment of the prostate in a canine 
model by Lee, et. al (2008).  Although this particular source does not focus on a human prostate, 
model parameters, such as the type of laser used, laser wattages, and run time, were comparable 
to the parameters that were used in this model.  Because of such similarities, this research paper 
was used as a validation source for which the model‟s results could be compared and accuracy 
could be checked.  Validations revealed that both the simulated and experimental results for 
coagulation  and  vaporization  thicknesses  followed  the  same  trend,  but  differed  in  thickness 
magnitude by factors of two or smaller.  The differences in magnitude occurred because of the 
slight differences in tissue properties between a human and canine prostate.  The comparable 
data trends, however, verified the feasibility and correctness of the model.       
 
4.2 Design Recommendations 
(1) Model the prostate with the “walnut” geometry.  The prostate model that we have created 
using the COMSOL software is  a simplified two-dimensional  model representing the 
structural and functional physics of a genuine prostate approximated as a cylinder to 
simplify the geometry.  To have a more accurate model, it would be necessary to take 
into account the “walnut” geometry of the prostate and to model it accordingly with 
attention to such fine details.   
(2) Include fluid flow mechanism that mimics and is comparable to a continuous bladder 
irrigation system that provides a cooling effect to the prostate‟s surrounding tissue so that 
the thermal energy given off by the KTP laser does not raise the temperature of or harm 
the surrounding healthy tissue regions.   12 
 
 
5. Discussion of Project Constraints 
 
5.1 Economic Constraints 
KTP laser treatment for benign prostatic hyperplasia is a fairly expensive medical treatment.  
The  cost  for  this  medical  treatment,  however,  is  still  lower  than  the  costs  for  comparable 
treatments, such as transurethral prostatectomy
(16).  BPH treatment using a KTP laser has been 
shown to have a success rate that is incomparable to any other BPH treatments.  The minimal 
failure rates of this treatment make it economically efficient as re-treatments are not necessary.  
Taking into consideration the short and long-term costs, BPH treatment with the KTP laser is the 
least expensive and the most cost efficient.     
 
5.2 Health and Safety Constraints 
Similar to any other medical treatment or medical modeling, the safety of the patient is of 
utmost importance at all times, under any condition.  One of the greatest advantages of this 
treatment method is the absence of blood during the surgical procedure since a laser is used to 
completely  destroy  the  enlarged,  excess  prostate  tissue.    Although  the  patient  does  undergo 
operation, he or she will remain in a relatively healthy condition, considering the fact that blood 
loss does not occur.  This non-invasive treatment greatly reduces post-operative health risks that 
could form with time after completion of the surgery.  KTP laser prostatectomy is a method of 
high  effectiveness,  providing  the  patients  with  an  excellent  short  and  long-term  functional 
outcome, whereas at the same time the method has a low morbidity 
(16).   
A health problem that could arise from the medical procedure is the application of the laser.  
More specifically, laser wattage could be too strong or laser application time could be too long, 
or heat generated from the laser could be so high that this heat could diffuse to the surrounding 
region of healthy tissue.  This could result in inadvertent coagulation and vaporization of healthy 
surrounding tissue, which is a specific problem that this model attempted to reduce and/or avoid. 
 
5.3 Modeling Constraints 
(1) Total amount of time for which the model can be run, as well as the size of the time steps.  
Because unlimited time is not provided, it is crucial to have the model successfully run 
within a desired range of time with time steps that are large enough so that the model can 
run at a quicker speed, but small enough so that the results are accurate.      
(2) Difficulty  in  incorporating  a  continuous  bladder  irrigation  system  to  the  COMSOL 
model.  In a real KTP laser treatment for BPH, the procedure not only focuses on laser 
application  for  tissue  coagulation  and  ablation,  but  also  uses  a  continuous  bladder 
irrigation system.  This irrigation system ensures that the high temperature heat directed 
to the prostate does not affect the surrounding tissue and provides a cooling effect for the 
tissue region surrounding the prostate.  Such a bladder irrigation system is crucial for the 
cooling of surrounding tissues that could be heated due to the high temperature heat that 
is generated from the KTP laser targeting the prostate.  Limited sources and knowledge 
of this system prohibited its inclusion in the model.  With further background information 
of this system, the current model could be expanded to include irrigation and create a 
more complex, advanced, and accurate model in the future. 
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6. Appendices  
 
6.1 Appendix A: Mathematical statement of the problem 
 
Governing equations 
 
Heat Transfer Equation (transient, conduction, source term): 
 
    (1) 
 
where: 
          (2) 
 
To obtain the heat source term, Q, the heat source from light diffusion differential equation was 
solved for   (3).   
 
Heat Source from Light Diffusion: 
 
      (3) 
 
where : 
      (4) 
Since vaporization of tissue is the result of vaporization of the water within the tissue, it 
causes  a  decrease  in  tissue  moisture  content.    Also,  the  absorption  (μa)  and  scattering  (μs) 
coefficients, which govern the laser-tissue interaction, are determined primarily by the tissue‟s 
water content.   To account for the effect of vaporization on the heat source term, the effect of 
moisture content on the absorption (μa) and scattering (μs) coefficients was considered.  Since Q 
is directly proportional to μa and only indirectly related to μs through D, it was assumed that μa 
affects Q much more than μs.  Thus, μs was assumed to remain constant and μa was assumed to 
vary linearly with moisture content such that μa equals zero when m equals zero and μa equals μa0 
when m equals m0 (5). 
 
          (5) 
 
To obtain μa, an additional mass diffusion model was used to determine m, the moisture content 
of the tissue (6 & 7).   
  
Mass Diffusion Model: 
  
     (6) 
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       (7)  
 
With δts set to 1 and D equal to zero (no diffusion of moisture), this reduced to: 
 
          (8) 
 
The reaction rate term, R a, relates the heat generated (Q) to the heat of vaporization (λ) 
giving the amount of water vaporized. Using the logic statement (T>373), a reaction rate was 
only present when the tissue temperature reached 100 C.  In other words, initially heat was used 
to increase the temperature of the tissue to 100 C and any additional heat absorbed was used to 
evaporate the water in the tissue.  These equations, therefore, model the effect that the moisture 
content has on Q, with  a modeled as a function of moisture content.  As moisture content 
decreases  a also decreases.  Due to the long solving times (90 minutes for our 1 second model), 
the moisture content diffusion model was not implemented in the surrounding tissue and μa was 
kept constant as μa0.  The following three tables define the parameters (Table 6.1.1), the initial 
conditions  (Table  6.1.2),  and  the  boundary  conditions  (Table  6.1.3)  that  are  used  in  the 
governing equations as described above. 
 
Table 6.1.1.  Input Parameters for COMSOL: Parameter symbols are defined in this table, as 
well as an indication of the source of the value or if it was solved for.  The full references for 
these papers can be found in Appendix D. 
  Parameter  Value  Measurement Unit  Source 
  Density  1090  kg/m
3  Zhang, et al 
cp  Heat Capacity  3500  J/kg 
oC  Zhang, et al 
K  Thermal Conductivity  0.41  W/m 
oC  Zhang, et al 
D  Optical Diffusion 
Coefficient 
2.41E4  m
2/s  Solved 
C*  Speed of Light (in tissue)  2.18E8  m/s  Jacques 
C0  Speed of Light (in 
vacuum) 
3.0E8  m/s  Zhang, et al 
a  Absorption Coefficient  236  m
-1  Zhang, et al 
s  Scattering Coefficient  13240  m
-1  Zhang, et al 
G  Optical Anisotropy Factor  0.79  unitless  Zhang, et al 
“  Spot Size  0.01  m  Zhang, et al 
“  Spot Size Area  7.85398E-05            m
2  Zhang, et al 
R  Reflection Ratio  0.1  unitless  Shafirstein 
P(t)  Laser Irradiance  1018591.636      W/m
2  Elzayat 
“  Applied Laser Power  80  W  Elzayat 
“  Laser Wavelength  532  nm  Elzayat 
Λ  Latent Heat of Water  40860  J/mol  Datta 
m0  Initial Moisture Content  42388.89  mol/m
3  Solved 
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Table 6.1.2. Initial Conditions. 
Parameter  Prostate  Surrounding Tissue 
T   310 K  310K 
Φ  0  0 
m  42388.89 mol/m
3  42388.89 mol/m
3 
 
 
 
 
Table 6.1.3. Boundary Conditions.  
Boundary  Heat Transfer (T)  Light Diffusion (φ)  Moisture (m) 
Prostate/Urethra  Thermal Insulation  Equation (2)  Insulation 
Vertical Axis  Axial Symmetry  Axial Symmetry  Axial Symmetry 
All Other External  Thermal Insulation  Insulation  Insulation 16 
 
6.2 Appendix B: Solution Strategy 
The solution was implemented in COMSOL using three simultaneous governing equations, 
two for diffusion (water concentration and light concentration, phi) and one for heat transfer. A 
direct solver (UMFPACK) was used to solve these equations. Ten time steps of length 0.1s were 
taken between 0 and 1s. The relative and absolute tolerances were 0.01 and 0.001, respectively. 
Initially a coarse mesh was used; however, the optimum mesh was determined by increasing 
the  mesh  until  the  solution  converged  (Figure  6.2.1).  The  final  mesh  consists  of  6825 
quadrilateral elements, with 425 boundary and 9 vertex elements (Figure 6.2.2).   
The element quality of the final mesh is fairly high in the region of interest, the prostate, 
which suggests the values from these elements will be reasonable (Figure 6.2.3). The quality in 
parts of the surrounding tissue is low, but this is acceptable because the temperature in the tissue 
does not change significantly.   
 
 
Figure 6.2.1.  Mesh Convergence Analysis: By plotting the average temperature in the prostate 
with respect to the number of mesh elements, mesh convergence was obtained.  The average 
temperature  in  the  prostate  remains  constant  between  6825  to  9675  mesh  elements,  which 
indicated that a converged solution has been achieved. 17 
 
 
Figure 6.2.2. Domain Mesh: Simple mapped mesh created for subdomain 1 (surrounding) with a 
total of 4375 elements and an element area ratio of 0.0510 and subdomain 2 (prostate) with a 
total of 2450 elements and an element area ratio of 0.500.  The left edge of the surrounding tissue 
and edge at the top of the urethra region have 20 elements, the left and right edges of the prostate 
have 35 elements, and the top and bottom edges of the prostate have 70 elements.   
 
Figure 6.2.3. Mesh Quality: The element quality of each element in the final mesh. This plot 
shows that in the region of interest (the prostate) the quality is fairly high, but it is lower in the 
surrounding tissue. 18 
 
6.3 Appendix C: Additional Visuals 
     
 
Figure 6.3.1.  Temporal Temperature Change: Plot of temperature at point (.005, .005) for a time 
of 1 second. 
 
Figure  6.3.2.  Water  Concentration:  Surface  plot  of  the  water  concentration  (mol/m
3)  in  the 
prostate after 1s of laser heating. Notice this high water concentration (shown in red) in most of 
the prostate. This is consistent with our temperature contour plot which indicates vaporization 
only in the first few millimeters of the prostate. 19 
 
 
Figure 6.3.3. Contour Plot for 1 second at 60 W: Vaporization depth is 0.939 mm and the 
coagulation depth is 0.805 mm. 
 
 
Figure 6.3.4. Contour Plot for 1 second at 120 W: Vaporization depth is 1.539mm and the 
coagulation depth is 0.761mm. 
 20 
 
 
Figure  6.3.5.  Contour  plot  for  5  seconds  at  40W.  Vaporization  depth  is  1.849mm  and  the 
coagulation depth is 1.171mm. 
 
Figure 6.3.6. Contour plot for 5 seconds at 80W. Vaporization depth is measured to be 3.066 
mm, and the coagulation depth is 0.892 mm. 21 
 
 
Figure 6.3.7.  Contour plot for 5 seconds  at  120W:  Vaporization and coagulation depths  are 
measured to be 3.893 mm and 0.797 mm, respectively. 
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6.4 Appendix D 
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